QA: Bionexus Gene Lab Corp in us_health_services/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001737523_2024_Bionexus_Gene_Lab_Corp.pdf

Logs

info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Liabilities', 'missing_ratio': 0.05991389987582024, 'aggregate_val': 1741941, 'exp_sum': 1852959, 'exp_to_value': {'LongTermLiabilities': 111018, 'LiabilitiesCurrent': 1643178, 'remainder_Liabilities': 98763}}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Assets', 'missing_ratio': 0.22727863062610681, 'aggregate_val': 11399793, 'exp_sum': 14752786, 'exp_to_value': {'IntangibleAssets': 0, 'AssetsNonCurrent': 3352993, 'AssetsCurrent': 8046800, 'PropertyPlantAndEquipment': 1511618, 'remainder_Assets': 1841375}}

Graph

Absolute values for 0001737523, Bionexus Gene Lab Corp

  xvar xval
0 IntangibleAssets 0
1 AssetsNonCurrent 3,352,993
2 AssetsCurrent 8,046,800
3 PropertyPlantAndEquipment 1,511,618
4 remainder_Assets -1,511,618
5 LongTermLiabilities 111,018
6 LiabilitiesCurrent 1,643,178
7 remainder_Liabilities -12,255
8 LaborExpense 0
9 CostOfGoodsAndServicesSold 8,441,308
10 GeneralAndAdministrativeExpense 4,409,122
11 GoodwillImpairmentLoss 0
12 OperatingCostsAndExpenses 0
13 DepreciationDepletionAndAmortization 0
14 SellingAndMarketingExpense 0
15 ResearchAndDevelopmentExpense 0
16 remainder_Expenses -21,526
17 remainder_Revenues 10,256,842
18 remainder_NetIncome -13,929
19 remainder_ComprehensiveNetIncome -268,232
  yvar yval
0 Assets 11,399,793
1 Liabilities 1,741,941
2 Expenses 12,828,904
3 Revenues 10,256,842
4 StockholdersEquity 9,657,852
5 NetIncome -2,585,991
6 ComprehensiveNetIncome -2,854,223
7 BaseVar 18,254,820
8 EconomicCapitalRatio 3.65

Edgar->Model Mapping

Feature Distribution

Change over Time